Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs ↧ ↧ Wegovy-maker Novo faces calls to map out strategy beyond weight-los... Wegovy-maker Novo Nordisk's CEO Mike Doustdar will face pressure on Monday to set out his strategy for competing with US rival Eli Lilly and how he plans to boost the company's growth beyond the blockbuster weight-loss drug.
published
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs ↧
Open the original public source →
Latest documented BWB result
$APP market result
I Sold the $APP $310 Puts for Friday for $3 - been selling Puts on $APP every week with that hard floor of $300 and the high premium
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.